Aldeyra Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aldeyra Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q2 2024.
  • Aldeyra Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$18M, a 74.1% decline year-over-year.
  • Aldeyra Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$43M, a 22.6% increase year-over-year.
  • Aldeyra Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$42.8M, a 31.7% increase from 2022.
  • Aldeyra Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$62.7M, a 11.5% decline from 2021.
  • Aldeyra Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$56.2M, a 54.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$43M -$18M -$7.67M -74.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$35.4M -$9.39M +$7.41M +44.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$42.8M -$6.1M +$7.6M +55.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$50.4M -$9.55M +$5.23M +35.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 -$55.6M -$10.3M +$7.37M +41.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$63M -$16.8M -$320K -1.94% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$62.7M -$13.7M +$1.71M +11.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$64.4M -$14.8M +$657K +4.25% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$65M -$17.7M -$3.17M -21.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$61.9M -$16.5M -$5.65M -52.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$56.2M -$15.4M -$4.12M -36.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$52.1M -$15.4M -$7.05M -84.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$45.1M -$14.5M -$7.44M -105% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$37.6M -$10.8M -$1.19M -12.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$36.4M -$11.3M +$1.61M +12.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$38M -$8.39M +$10.6M +55.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 -$48.7M -$7.11M +$6.63M +48.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$55.3M -$9.64M +$7.79M +44.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$63.1M -$12.9M -$1.8M -16.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$61.3M -$19M -$8.07M -73.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$53.2M -$13.7M -$4.57M -49.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$48.6M -$17.4M -$8.94M -105% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$39.7M -$11.1M -$4.05M -57.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$35.7M -$10.9M -$5.93M -118% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$29.7M -$9.17M -$3.84M -71.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$25.9M -$8.49M -$3.4M -66.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$22.5M -$7.05M -$2.39M -51.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 -$20.1M -$5.02M -$239K -5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$19.9M -$5.33M -$1.03M -24.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$18.8M -$5.1M -$129K -2.59% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 -$18.7M -$4.66M -$317K -7.3% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-30
Q3 2016 -$18.4M -$4.78M -$1.44M -43.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$16.9M -$4.3M -$2.09M -95% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$14.8M -$4.97M -$2.86M -136% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$12M -$4.34M -$1.93M -80% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$10.1M -$3.34M -$1.37M -69.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$8.69M -$2.2M -$557K -33.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 -$8.13M -$2.11M -$864K -69.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$7.27M -$2.41M -$1.18M -95.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$6.09M -$1.97M -$802K -68.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$5.29M -$1.65M -$661K -67% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$4.63M -$1.24M -$953K -327% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$3.68M -$1.23M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-23
Q3 2013 -$1.17M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$986K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$292K Jan 1, 2013 Mar 31, 2013 10-Q 2014-06-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.